Barbara L.   Andersen

Dr. Barbara L. Andersen


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2008 in Cancer
Verified
Journal Article
Open access
PDF file
BABarbara L. Andersen
Barbara L. Andersen
HYHae‐Chung Yang
Hae‐Chung Yang
WFWilliam B. Farrar
William B. Farrar
DGDeanna M. Golden‐Kreutz
Deanna M. Golden‐Kreutz
CECharles F. Emery
Charles F. Emery
WCWilliam E Carson
William E Carson
BACKGROUND.: The question of whether stress poses a risk for cancer progression has been difficult to answer. A randomized clinical trial tested the hypothesis that cancer patients coping with their recent diagnosis but receiving a psychologic intervention would have improved survival compared with patients who were only assessed.METHODS.: A total of 227 patients who were surgically treated for regional breast cancer participated. Before beginning adjuvant cancer therapies, patients were assessed with psychologic and behavioral measures and had a health evaluation, and a 60‐mL blood sample was drawn. Patients were randomized to Psychologic Intervention plus assessment or Assessment only study arms. The intervention was psychologist led; conducted in small groups; and included strategies to reduce stress, improve mood, alter health behaviors, and maintain adherence to cancer treatment and care. Earlier articles demonstrated that, compared with the Assessment arm, the Intervention arm improved across all of the latter secondary outcomes. Immunity was also enhanced.RESULTS.: After a median of 11 years of follow‐up, disease recurrence was reported to occur in 62 of 212 (29%) women and death was reported for 54 of 227 (24%) women. Using Cox proportional hazards analysis, multivariate comparison of survival was conducted. As predicted, patients in the Intervention arm were found to have a reduced risk of breast cancer recurrence (hazards ratio [HR] of 0.55; P = .034) and death from breast cancer (HR of 0.44; P = .016) compared with patients in the Assessment only arm. Follow‐up analyses also demonstrated that Intervention patients had a reduced risk of death from all causes (HR of 0.51; P = .028).CONCLUSIONS.: Psychologic interventions as delivered and studied here can improve survival. Cancer 2008. © 2008 American Cancer Society.

20 June 2023 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
BABarbara L. Andersen
Barbara L. Andersen
CLChristina Lacchetti
Christina Lacchetti
KAKimlin Ashing
Kimlin Ashing
JBJonathan S. Berek
Jonathan S. Berek
BBBarry S. Berman
Barry S. Berman
JRJulia H. Rowland
Julia H. Rowland
PURPOSE: To update the American Society of Clinical Oncology guideline on the management of anxiety and depression in adult cancer survivors.METHODS: A multidisciplinary expert panel convened to update the guideline. A systematic review of evidence published from 2013-2021 was conducted.RESULTS: The evidence base consisted of 17 systematic reviews ± meta analyses (nine for psychosocial interventions, four for physical exercise, three for mindfulness-based stress reduction [MBSR], and one for pharmacologic interventions), and an additional 44 randomized controlled trials. Psychological, educational, and psychosocial interventions led to improvements in depression and anxiety. Evidence for pharmacologic management of depression and anxiety in cancer survivors was inconsistent. The lack of inclusion of survivors from minoritized groups was noted and identified as an important consideration to provide high-quality care for ethnic minority populations.RECOMMENDATIONS: It is recommended to use a stepped-care model, that is, provide the most effective and least resource-intensive intervention based on symptom severity. All oncology patients should be offered education regarding depression and anxiety. For patients with moderate symptoms of depression, clinicians should offer cognitive behavior therapy (CBT), behavioral activation (BA), MBSR, structured physical activity, or empirically supported psychosocial interventions. For patients with moderate symptoms of anxiety, clinicians should offer CBT, BA, structured physical activity, acceptance and commitment therapy, or psychosocial interventions. For patients with severe symptoms of depression or anxiety, clinicians should offer cognitive therapy, BA, CBT, MBSR, or interpersonal therapy. Treating clinicians may offer a pharmacologic regimen for depression or anxiety for patients who do not have access to first-line treatment, prefer pharmacotherapy, have previously responded well to pharmacotherapy, or have not improved following first-line psychological or behavioral management. Additional information is available at www.asco.org/survivorship-guidelines .

1 September 2004 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
BABarbara L. Andersen
Barbara L. Andersen
WFWilliam B. Farrar
William B. Farrar
DGDeanna M. Golden-Kreutz
Deanna M. Golden-Kreutz
RGRonald Glaser
Ronald Glaser
CECharles F. Emery
Charles F. Emery
WCWilliam E Carson
William E Carson
Purpose: This randomized clinical trial tests the hypothesis that a psychological intervention can reduce emotional distress, improve health behaviors and dose-intensity, and enhance immune responses. Patients and Methods: We studied 227 women who were surgically treated for regional breast cancer. Before adjuvant therapy, women completed interviews and questionnaires assessing emotional distress, social adjustment, and health behaviors. A 60-mL blood sample was drawn for immune assays. Patients were randomly assigned to either the intervention group or assessment only group. The intervention was conducted in small patient groups, with one session per week for 4 months. The sessions included strategies to reduce stress, improve mood, alter health behaviors, and maintain adherence to cancer treatment and care. Reassessment occurred after completion of the intervention. Results: As predicted, patients receiving the intervention showed significant lowering of anxiety, improvements in perceived social support, improved dietary habits, and reduction in smoking (all P < .05). Analyses of adjuvant chemotherapy dose-intensity revealed significantly more variability (ie, more dispersion in the dose-intensity values) for the assessment arm (P < .05). Immune responses for the intervention patients paralleled their psychological and behavioral improvements. T-cell proliferation in response to phytohemagglutinin and concanavalin A remained stable or increased for the Intervention patients, whereas both responses declined for Assessment patients; this effect was replicated across three concentrations for each assay (all P < .01). Conclusion: These data show a convergence of significant psychological, health behavior, and biologic effects after a psychological intervention for cancer patients.

7 January 1998 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
BABarbara L. Andersen
Barbara L. Andersen
WFWilliam B. Farrar
William B. Farrar
DGDeanna Golden-Kreutz
Deanna Golden-Kreutz
LKLeigh Ann Kutz
Leigh Ann Kutz
RMRobert MacCallum
Robert MacCallum
RGRonald Glaser
Ronald Glaser
Background: Adults who undergo chronic stress, such as the diagnosis and surgical treatment of breast cancer, often experience adjustment difficulties and important biologic effects. This stress can affect the immune system, possibly reducing the ability of individuals with cancer to resist disease progression and metastatic spread. We examined whether stress influences cellular immune responses in patients following breast cancer diagnosis and surgery. Methods: We studied 116 patients recently treated surgically for invasive breast cancer. Before beginning their adjuvant therapy, all subjects completed a validated questionnaire assessing the stress of being cancer patients. A 60-mL blood sample taken from each patient was subjected to a panel of natural killer (NK) cell and Tlymphocyte assays. We then developed multiple regression models to test the contribution of psychologic stress in predicting immune function. All regression equations controlled for variables that might exert short-or longterm effects on these responses, and we also ruled out other potentially convariables. Results: We found, reproducibly between and within as says, the following: 1) Stress level significantly predicted lower NK cell lysis, 2) stress level significantly predicted diminished response of NK cells to recombinant interferon gamma, and 3) stress level significantly predicted deproliferative response of peripheral blood lymphocytes to plant lectins and to a monoclonal antibody directed against the T-cell receptor. Conclusions: The data show that the physiologic effects of stress inhibit cellular immune responses that are relevant to cancer prognosis, including NK cell toxicity and T-cell responses. Additional, longitudinal studies are needed to determine the duration of these effects, their health consequences, and their biologic andbehavioral mechanisms. [J Natl Cancer Inst 1998; 90:30–6]

3 June 2003 in Psycho-Oncology
Verified
Journal Article
Closed access
PDF file
DGDeanna M. Golden‐Kreutz
Deanna M. Golden‐Kreutz
BABarbara L. Andersen
Barbara L. Andersen

1 January 2005 in Health Psychology
Verified
Journal Article
Closed access
DGDeanna M. Golden-Kreutz
Deanna M. Golden-Kreutz
LTLisa M. Thornton
Lisa M. Thornton
SGSharla Wells-Di Gregorio
Sharla Wells-Di Gregorio
GFGeorita M. Frierson
Georita M. Frierson
HJHeather S. Jim
Heather S. Jim
BABarbara L. Andersen
Barbara L. Andersen
The authors investigated the relationship between stress at initial cancer diagnosis and treatment and subsequent quality of life (QoL). Women (n = 112) randomized to the assessment-only arm of a clinical trial were initially assessed after breast cancer diagnosis and surgery and then reassessed at 4 months (during adjuvant treatment) and 12 months (postadjuvant treatment). There were 3 types of stress measured: number of stressful life events (K. A. Matthews et al., 1997), cancer-related traumatic stress symptoms (M. J. Horowitz, N. Wilner, & W. Alvarez, 1979), and perceived global stress (S. Cohen, T. Kamarck, & R. Mermelstein, 1983). Using hierarchical multiple regressions, the authors found that stress predicted both psychological and physical QoL (J. E. Ware, K. K. Snow, & M. Kosinski, 2000) at the follow-ups (all ps < .03). These findings substantiate the relationship between initial stress and later QoL and underscore the need for timely psychological intervention.